SRHE:LSE:LSE-Amundi Index Solutions - Amundi Index MSCI EMU SRI PAB Ucits ETF DR Cap GBX (GBX)

ETF | Others |

Last Closing

USD 7172

Change

-41.50 (-0.58)%

Market Cap

USD 0.23B

Volume

360.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.29 (+0.47%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-15.00 (-7.16%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.47 (-0.32%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.12 (+0.85%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.08 (+0.44%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.35 (-0.55%)

USD 266.08B
0QZO:LSE 0QZO

+1.40 (+1.42%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.15 (+0.48%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

-1.90 (-1.12%)

USD 202.26B

ETFs Containing SRHE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.18% 46% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.18% 46% F 51% F
Trailing 12 Months  
Capital Gain 12.12% 46% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.12% 46% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.75% 53% F 59% D-
Dividend Return 6.75% 53% F 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.95% 81% B- 90% A-
Risk Adjusted Return 97.17% 91% A- 95% A
Market Capitalization 0.23B 62% D 35% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike